Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Accounts Payables (2018 - 2025)

Historic Accounts Payables for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $1.5 million.

  • Neurogene's Accounts Payables fell 831.35% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 831.35%. This contributed to the annual value of $1.3 million for FY2024, which is 4853.62% down from last year.
  • Neurogene's Accounts Payables amounted to $1.5 million in Q3 2025, which was down 831.35% from $2.1 million recorded in Q2 2025.
  • Neurogene's 5-year Accounts Payables high stood at $5.4 million for Q1 2023, and its period low was $1.3 million during Q4 2024.
  • Its 3-year average for Accounts Payables is $2.5 million, with a median of $2.1 million in 2025.
  • As far as peak fluctuations go, Neurogene's Accounts Payables tumbled by 7192.4% in 2024, and later skyrocketed by 10124.84% in 2025.
  • Over the past 3 years, Neurogene's Accounts Payables (Quarter) stood at $2.6 million in 2023, then tumbled by 48.54% to $1.3 million in 2024, then rose by 15.57% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $2.1 million for Q2 2025, and $3.1 million during Q1 2025.